Is Fibromyalgia hereditary?

Fibromyalgia is considered a multifactorial condition, meaning it is influenced by a complex interplay of genetic predispositions and environmental triggers rather than being a strictly hereditary disease caused by a single gene mutation.

Genetic vs. Hereditary Factors

While Fibromyalgia is not "hereditary" in the sense of following simple Mendelian patterns like cystic fibrosis, it does show familial aggregation. Research suggests that a person’s genetic makeup can increase their vulnerability to developing the condition. Because it is multifactorial, the risk for a child of a parent with Fibromyalgia is difficult to quantify precisely, but studies indicate that first-degree relatives of affected individuals are approximately eight times more likely to develop the disorder compared to the general population.

Genetic Testing and Counseling

Currently, there is no validated clinical genetic test for Fibromyalgia. Because the condition is polygenic—involving many small variations across multiple genes—genetic testing is not recommended for diagnosis or risk assessment. Consequently, carrier testing and prenatal diagnosis are not applicable for this condition. Genetic counseling can still be valuable for families, however, by helping to contextualize the familial nature of Fibromyalgia, managing expectations regarding symptom inheritance, and providing support for those navigating the psychological impact of a chronic, often invisible, condition.

De Novo Mutations and Research

There is no evidence to suggest that Fibromyalgia is caused by de novo (spontaneous) mutations. Instead, current research focuses on how genetic variations in the central nervous system, particularly those related to serotonin and dopamine signaling, interact with environmental stressors, trauma, or infections to trigger the onset of chronic pain. Understanding these genetic markers remains an active area of study, but the condition remains a clinical diagnosis based on symptom presentation rather than molecular markers.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• OMIM (Online Mendelian Inheritance in Man): Entry for Fibromyalgia